Streamlining Stem Cell Manufacturing

April 25, 2017

(Genetic Engineering & Biotechnology News) – Stem cell therapies hold extraordinary potential to revolutionize human medicine. Indeed, the global market for cell-based therapies is expected to surpass $20 billion by 2025, with an annual growth rate of 21%, as estimated by Scientia Advisors. Because stem cells have the ability to transform into a variety of cell types, stem cell therapeutic targets include cancer, neurodegenerative disease, heart disease, autoimmune disease, and musculoskeletal disorders. The choice of which stem cells to pursue for clinical applications depends both on their potential clinical risks and accessibility.